Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Antimicrobial Resistance Surveillance Market Grown from 2024 to 2025?
There has been substantial growth in the antimicrobial resistance surveillance market in recent years. The market size will experience an increase from $6.77 billion in 2024 to $7.36 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.7%. Factors contributing to the growth during the historical period include the escalated usage of antibiotics in agriculture, the practice of overprescribing antibiotics in healthcare, the shortage of diagnostic testing, inadequate infection prevention and management practices, as well as global travel and commerce.
What Growth Rate Is Anticipated for the Antimicrobial Resistance Surveillance Market in the Coming Years?
The market size for antimicrobial resistance surveillance is predicted to experience robust growth in the coming years. It is expected to surge to $10.18 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 8.5%. The projected growth during this period can be accredited to the escalating awareness of antimicrobial resistance, progression in diagnostic technologies, a surge in government initiatives and financial support, an increase in infections associated with healthcare, and the inception of novel antibiotics and alternatives. Noteworthy trends in the forecast period include the use of artificial intelligence for data interpretation, next-gen sequencing technologies, real-time monitoring systems, molecular diagnostic instruments, and the coupling of vast data and machine learning for predictive analysis.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp
Who Are the Leading Companies in the Antimicrobial Resistance Surveillance Market?
Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Viatris Inc., Wolters Kluwer NV, Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen NV, Cepheid Inc., Shionogi & Co. Ltd., Venatorx Pharmaceuticals Inc., Accelerate Diagnostics Inc., Paratek Pharmaceuticals Inc., Liofilchem Srl, Lumed Inc., OpGen Inc.
What Are the Key Drivers of the Antimicrobial Resistance Surveillance Market?
The escalating occurrence of infectious diseases is anticipated to drive the expansion of the antimicrobial resistance surveillance market in the future. Infectious diseases, which result from harmful microorganisms such as bacteria, viruses, fungi, or parasites, can be transmitted directly or indirectly from person to person. The surge in such diseases is linked to aspects like climate change, urbanization, and international travel, contributing to the spread of pathogens and exposure of humans to new microbes. Surveillance of antimicrobial resistance contributes to monitoring the proliferation of resistant pathogens, leading to effective treatment approaches, and shaping public health policies to fight infectious diseases. For example, in February 2024, the UK Health Security Agency, a government entity in the UK, released a report stating that tuberculosis (TB) cases in England had surged by 10.7% in 2023, recording 4,850 cases as compared to 4,380 in the previous year – 2022. Consequently, the escalating occurrence of infectious diseases bolsters the growth of the antimicrobial resistance surveillance market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21100&type=smp
What Are the Key Market Segments in the Antimicrobial Resistance Surveillance Industry?
The antimicrobial resistance surveillance market covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
What Are the Latest Trends in the Antimicrobial Resistance Surveillance Market?
Corporations who are leading players in the marketplace are focusing their efforts on the development of innovative technologies like advanced diagnostic tools, to streamline operations, enhance performance, make precision advancements, cut costs, and provide better results for patients and end users. A diagnostic tool is defined as any device, instrument, software, or procedure designed to identify, discover, or evaluate a condition, illness, malfunction, or problem. For instance, Sysmex Astrego AB, a company based in Sweden that manufactures and provides services related to diagnostic products, revealed in June 2023 that they have initiated the PA-100 AST Point-of-Care Testing System. This system aids in quickly and accurately identifying antimicrobial resistance at the point of treatment, resulting in significantly reduced timeframe as compared to traditional lab methods, which can take days. By offering results within 30 minutes, it enables physicians to make timely, informed decisions about the best treatment protocol for infections, thus reducing the dependence on broad-spectrum antibiotics and assisting in controlling the rise of antimicrobial resistance.
Access The Full Report Here:
What Are the Key Regional Markets in the Antimicrobial Resistance Surveillance Industry?
North America was the largest region in the antimicrobial resistance surveillance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21100
This Report Delivers Insight On:
1. How big is the antimicrobial resistance surveillance market, and how is it changing globally?
2. Who are the major companies in the antimicrobial resistance surveillance market, and how are they performing?
3. What are the key opportunities and risks in the antimicrobial resistance surveillance market right now?
4. Which products or customer segments are growing the most in the antimicrobial resistance surveillance market?
5. What factors are helping or slowing down the growth of the antimicrobial resistance surveillance market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
